EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Testing the feasibility of blood flow restriction training to enhance the HEALTH benefits of exercise in individuals with type 2 diabetes (BOOST-HEALTH Trial): Study Protocol

Amy M Thomson, Seth F McCarthy iD, Jamie F Burr, Jonathan P Little, Maryam Kebbe, Martin Sénéchal iD

PLOS One · 30.03.2026 · 21 (3) · e0346176

DOI: 10.1371/journal.pone.0346176 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS One, online erschienen am 30.03.2026. Verfasst von Amy M Thomson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiometabolic Exercise & Lifestyle Laboratory, Fredericton, New Brunswick, Canada. Hauptthemen laut MEDLINE: Blood Flow Restriction Therapy, Diabetes Mellitus, Type 2, Exercise, Exercise Therapy. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Diabetes Canada and the River Philip Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Individuals with type 2 diabetes (T2D) display reduced cardiorespiratory fitness, a strong predictor of premature mortality and T2D-related complications. Aerobic training (AT) enhances cardiorespiratory fitness and is a cornerstone in T2D management. Emerging data suggest that AT combined with blood flow restriction (AT+BFR) may elicit greater improvements in cardiorespiratory fitness than typical AT in healthy individuals. However, the feasibility and effects of AT+BFR in individuals with T2D remain unclear.

Objectives

This protocol describes the BOOST-HEALTH trial, which aims to 1) evaluate the feasibility of a 6-week AT+BFR intervention in adults with T2D, and 2) estimate preliminary effect sizes for changes in cardiorespiratory fitness, glycemic outcomes, and quality of life compared with standard care AT (AT- stdCare).

Methods

BOOST-HEALTH (NCT07196371) is a single-blinded, multisite, randomized clinical pilot trial with two parallel treatment arms. Sixty adults with T2D (n = 30 female) will be randomized to 6 weeks of AT+BFR or AT-stdCare. Both groups will complete supervised treadmill walking three times per week (96 min/week) at 40–50% heart rate reserve. The AT+BFR group will exercise with BFR cuffs inflated to 60–80% of limb arterial occlusion pressure, whereas the AT-stdCare group will exercise without BFR. Primary outcomes will assess feasibility, including recruitment, enrollment, adherence, and retention. Secondary outcomes will estimate effect sizes for changes in cardiorespiratory fitness (VO 2max ) and continuous glucose monitoring metrics to inform outcome selection and sample size calculations for future definitive trials. Outcomes will be assessed at baseline and post-intervention.

Discussion

Results of this study could establish BFR training as a novel therapeutic modality to augment the effects of exercise in individuals with T2D. Findings will inform whether a larger, definitive efficacy trial is warranted and will guide exercise professionals on the potential integration of AT+BFR as an alternative strategy to enhance the benefits of exercise in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Flow Restriction TherapyDiabetes Mellitus, Type 2ExerciseExercise TherapyAdultFemaleHumansMaleMiddle AgedCardiorespiratory FitnessFeasibility StudiesPilot ProjectsQuality of LifeRandomized Controlled Trials as TopicSingle-Blind MethodMulticenter Studies as Topic

Autor:innen und Institutionen

  • Cardiometabolic Exercise & Lifestyle Laboratory, Fredericton, New Brunswick, Canada.
  • Faculty of Kinesiology, University of New Brunswick, Fredericton, New Brunswick, Canada.
  • Exercise, Metabolism and Inflammation Lab, Kelowna, British Columbia, Canada.
  • School of Health and Exercise Sciences, University of British Columbia, Kelowna, British Columbia, Canada.
  • Human Performance & Health Research Laboratory, Guelph, Ontario, Canada.
  • Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada.

ORCID-Profile: Seth F McCarthy, Martin Sénéchal

Förderung

  • Diabetes Canada and the River Philip Foundation

Zitieren

APA

Thomson, A. M., McCarthy, S. F., Burr, J. F., Little, J. P., Kebbe, M., & Sénéchal, M. (2026). Testing the feasibility of blood flow restriction training to enhance the HEALTH benefits of exercise in individuals with type 2 diabetes (BOOST-HEALTH Trial): Study Protocol. PLOS One, 21(3), e0346176. https://doi.org/10.1371/journal.pone.0346176

Vancouver

Thomson AM, McCarthy SF, Burr JF, Little JP, Kebbe M, Sénéchal M. Testing the feasibility of blood flow restriction training to enhance the HEALTH benefits of exercise in individuals with type 2 diabetes (BOOST-HEALTH Trial): Study Protocol. PLOS One. 2026;21(3):e0346176. doi:10.1371/journal.pone.0346176

BibTeX
@article{Thomson2026,
  author = {Thomson, Amy M and McCarthy, Seth F and Burr, Jamie F and Little, Jonathan P and Kebbe, Maryam and Sénéchal, Martin},
  title = {Testing the feasibility of blood flow restriction training to enhance the HEALTH benefits of exercise in individuals with type 2 diabetes (BOOST-HEALTH Trial): Study Protocol},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {e0346176},
  doi = {10.1371/journal.pone.0346176}
}
Kostenlos starten →